| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.995 | 0 | 0.995 | Glucocorticoid antagonist | 0.995 0 CID_154699824 | ||
| 0.993 | 0.002 | 0.993 | Toll-Like receptor agonist | 0.986 0.003 CID_154699824 | ||
| 0.993 | 0.002 | 0.993 | Toll-Like receptor 7 agonist | 0.986 0.003 CID_154699824 | ||
| 0.992 | 0.003 | 0.992 | Antiinflammatory | 0.989 0.003 CID_154699824 | ||
| 0.958 | 0 | 0.958 | Corticosteroid-like | 0.801 0 CID_154699824 | ||
| 0.946 | 0 | 0.946 | Glucocorticoid agonist | 0.873 0 CID_154699824 | ||
| 0.916 | 0 | 0.916 | Lipocortins synthesis agonist | 0.722 0 CID_154699824 | ||
| 0.751 | 0.003 | 0.751 | Antipruritic | 0.729 0.003 CID_154699824 | ||
| 0.703 | 0.004 | 0.703 | Hypoxia-inducible factor 1 alpha inhibitor | 0.552 0.01 CID_154699824 | ||
| 0.694 | 0.005 | 0.694 | Immunosuppressant | 0.682 0.005 CID_154699824 | ||
| 0.593 | 0.032 | 0.605 | Transcription factor NF kappa B inhibitor | 0.605 0.031 CID_154699824 | CID_154699824 | |
| 0.545 | 0.004 | 0.545 | Tumour necrosis factor antagonist | 0.432 0.005 CID_154699824 | ||
| 0.529 | 0.005 | 0.529 | Interferon gamma antagonist | 0.491 0.006 CID_154699824 | ||
| 0.469 | 0 | 0.469 | Arachidonic acid antagonist | 0.413 0 CID_154699824 | ||
| 0.421 | 0.023 | 0.421 | Nitric oxide antagonist | 0.41 0.024 CID_154699824 | ||
| 0.377 | 0.005 | 0.377 | Androgen antagonist | 0.356 0.005 CID_154699824 | ||
| 0.36 | 0.012 | 0.36 | Lipocortins synthesis antagonist | 0.349 0.014 CID_154699824 | ||
| 0.323 | 0.059 | 0.323 | Sodium/bile acid cotransporter inhibitor | 0.318 0.064 CID_154699824 | ||
| 0.266 | 0.004 | 0.266 | Androgen agonist | 0.203 0.005 CID_154699824 | ||
| 0.216 | 0.005 | 0.216 | Interleukin 5 antagonist | 0.193 0.005 CID_154699824 | ||
| 0.238 | 0.029 | 0.238 | NOS3 expression enhancer | 0.203 0.04 CID_154699824 | ||
| 0.2 | 0.004 | 0.2 | Mineralocorticoid receptor antagonist | 0.169 0.005 CID_154699824 | ||
| 0.215 | 0.057 | 0.215 | Hepatoprotectant | 0.196 0.068 CID_154699824 | ||
| 0.152 | 0.017 | 0.152 | Anabolic | 0.138 0.025 CID_154699824 | ||
| 0.166 | 0.037 | 0.166 | Interleukin 4 antagonist | 0.141 0.059 CID_154699824 | ||
| 0.091 | 0.004 | 0.091 | Progesterone agonist | 0.079 0.004 CID_154699824 | ||
| 0.095 | 0.009 | 0.095 | Progesterone antagonist | 0.048 0.019 CID_154699824 | ||
| 0.092 | 0.013 | 0.096 | Nitric oxide donor | 0.096 0.011 CID_154699824 | CID_154699824 | |
| 0.167 | 0.093 | 0.167 | P-glycoprotein inhibitor | 0.163 0.098 CID_154699824 | ||
| 0.119 | 0.058 | 0.119 | Estrogen antagonist | 0.112 0.071 CID_154699824 | ||
| 0.084 | 0.025 | 0.084 | Aromatase inhibitor | |||
| 0.062 | 0.011 | 0.062 | RNA-directed RNA polymerase stimulant | 0.056 0.012 CID_154699824 | ||
| 0.215 | 0.165 | 0.215 | Interleukin 2 agonist | 0.203 0.184 CID_154699824 | ||
| 0.089 | 0.042 | 0.095 | Na+ K+ transporting ATPase inhibitor | 0.095 0.036 CID_154699824 | CID_154699824 | |
| 0.18 | 0.132 | 0.18 | Antioxidant | 0.175 0.137 CID_154699824 | ||
| 0.117 | 0.071 | 0.117 | DNA polymerase I inhibitor | |||
| 0.058 | 0.017 | 0.058 | Microtubule stabilization | 0.057 0.019 CID_154699824 | ||
| 0.036 | 0.03 | 0.036 | Glucose-6-phosphate dehydrogenase inhibitor | |||
| 0.012 | 0.01 | 0.012 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.089 | 0.232 | 0.245 | Interleukin 6 antagonist | 0.245 0.024 CID_154699824 | CID_154699824 | |
| 0.049 | 0.345 | 0.162 | Interleukin antagonist | 0.162 0.109 CID_154699824 | CID_154699824 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |